Regarding body weight, a double knockdown of both Gsk3a and Gsk3b led to a decrease in body weight [41], whereas an overexpression of human GSK3B in mice skeletal muscle resulted in impaired glucose tolerance, hyperlipidemia and an increase in fat mass and body weight gain [42]. The gene discussed is GSK3B; the disease is hyperlipidemia.